November 4, 2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2024

Zinzino group revenue increased with a total of 20 %, compared with the previous year.

GOTHENBURG, Sweden, Nov. 4, 2024 /PRNewswire/ — The revenue in October for Zinzino’s sales markets increased by 20 % and amounted to SEK 190.0 (157.7) million. Faun Pharma’s external sales increased by 19 % and amounted to SEK 7.4 (6.2) million. Overall, the Group increased revenues by 20 % to SEK 197.4 (163.9) million compared with the previous year.

Accumulated revenue for January – October 2024 increased by 21 % to SEK 1691.7 (1402.4) million.

Revenues were distributed as follows:

Regions,MSEK	24-Oct	23-Oct	Change	YTD 2024	YTD 2023	Change
The Nordics	28.8	28.6	1 %	242.7	245.7	-1 %
Central Europe	53.7	41.7	29 %	448.1	344.7	30 %
East Europe	34.2	31.2	10 %	314,0	312.5	0 %
South & West Europe	36.6	26.3	39 %	301.1	206.5	46 %
The Baltics	10.1	10,0	1 %	79.6	76.8	4 %
North America	19.4	17.1	13 %	153.4	84.9	81 %
Asia-Pacific	5.5	2.0	175 %	53.1	43.0	23 %
Africa	1.7	0.8	113 %	12.5	10.8	16 %
Zinzino	190.0	157.7	20 %	1604.5	1324.9	21 %
Faun Pharma	7.4	6.2	19 %	87.2	77.5	13 %
Zinzino Group	197.4	163.9	20 %	1691.7	1402.4	21 %

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
–Central Europe: Austria, Germany, Switzerland
–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey
-The Baltics: Estonia, Latvia, Lithuania
–North America: Canada, USA, Mexico
–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
–Africa: South Africa